Summit Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Summit Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SMMT
Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI).
CEORobert William Duggan
CEORobert William Duggan
Employees159
Employees159
HeadquartersMiami, Florida
HeadquartersMiami, Florida
Founded2003
Founded2003
Employees159
Employees159
SMMT Key Statistics
Market cap13.28B
Market cap13.28B
Price-Earnings ratio-14.35
Price-Earnings ratio-14.35
Dividend yield—
Dividend yield—
Average volume2.45M
Average volume2.45M
High today$17.90
High today$17.90
Low today$17.10
Low today$17.10
Open price$17.16
Open price$17.16
Volume3.60M
Volume3.60M
52 Week high$36.91
52 Week high$36.91
52 Week low$15.55
52 Week low$15.55
Stock Snapshot
Summit Therapeutics(SMMT) stock is priced at $17.84, giving the company a market capitalization of 13.28B. It carries a P/E multiple of -14.35.
On 2025-12-20, Summit Therapeutics(SMMT) stock traded between a low of $17.10 and a high of $17.90. Shares are currently priced at $17.84, which is +4.3% above the low and -0.3% below the high.
The Summit Therapeutics(SMMT)'s current trading volume is 3.6M, compared to an average daily volume of 2.45M.
In the last year, Summit Therapeutics(SMMT) shares hit a 52-week high of $36.91 and a 52-week low of $15.55.
In the last year, Summit Therapeutics(SMMT) shares hit a 52-week high of $36.91 and a 52-week low of $15.55.
Analyst ratings
81%
of 16 ratingsBuy
81.3%
Hold
18.8%
Sell
0%
People also own
Based on the portfolios of people who own SMMT. This list is generated using Robinhood data, and it’s not a recommendation.